Editorial: Advances in neuromyelitis optica spectrum disorders

Editorial: Advances in neuromyelitis optica spectrum disorders

Bibliographic Details
Main Authors:	Yu Cai, Jodie M. Burton, Fu-Dong Shi, Wei Qiu, Yangtai Guan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Neurology
Subjects:	NMOSD MOGAD molecular mechanism biomarkers therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2022.1005164/full

Similar Items

Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder
by: Angelika Bauer, et al.
Published: (2022-11-01)

Relapsing neuromyelitis optica spectrum disorder
by: M Lakshmi Lavanya, et al.
Published: (2021-01-01)

The difference of the retinal structural and microvascular characteristics in patients with MOGAD-ON and AQP4-ON
by: Yajun Yao, et al.
Published: (2022-08-01)

AQP4-MOG Double-Positive Neuromyelitis Optica Spectrum Disorder: Case Report with Central and Peripheral Nervous System Involvement and Review of Literature
by: Antonio Luca Spiezia, et al.
Published: (2022-11-01)

COVID-19 and the risk of neuromyelitis optica spectrum disorder: a Mendelian randomization study
by: Dongren Sun, et al.
Published: (2023-07-01)

Predictive role of blood-based indicators in neuromyelitis optica spectrum disorders
by: Xiqin Fang, et al.
Published: (2023-04-01)

Editorial: Immune-mediated disorders of the spinal cord: Diagnosis, treatment strategies, and outcomes in the 21st century
by: Giulia Fadda, et al.
Published: (2022-11-01)

Expression of CD226 is upregulated on Tr1 cells from neuromyelitis optica spectrum disorder patients
by: Ping Chen, et al.
Published: (2022-06-01)

Diagnostic Potential of Two Novel Biomarkers for Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis
by: Ting Xu, et al.
Published: (2023-04-01)

Neuromyelitis Optica Spectrum Disorders (NMOSD); Diagnostic criteria (ORP-56)
by: Maryam Poursadeghfard
Published: (2023-01-01)

Helicobacter pylori infection may influence prevalence and disease course in myelin oligodendrocyte glycoprotein antibody associated disorder (MOGAD) similar to MS but not AQP4-IgG associated NMOSD
by: Chaithra Malli, et al.
Published: (2023-05-01)

Neuromyelitis optica spectrum disorder in Western China impacts employment and increases financial burden in women
by: Lin Han, et al.
Published: (2022-09-01)

Serum Albumin Level Can Predict Immunotherapy Response of Neuromyelitis Optica Spectrum Disorders in the Acute Phase
by: Xiang W, et al.
Published: (2024-02-01)

Editorial: Women in multiple sclerosis and other demyelinating disorders: A global perspective
by: Ethel Ciampi, et al.
Published: (2023-02-01)

Area postrema syndrome – a challenge for differential diagnosis between multiple sclerosis and neuromyelitis optica spectrum disorders
by: Adriana Octaviana Dulamea, et al.
Published: (2017-12-01)

Editorial: Neuroglial antibodies: From clinical associations to pathophysiological investigations
by: Alberto Vogrig, et al.
Published: (2023-02-01)

Hematopoietic Stem Cell Transplantation in Neuromyelitis Optica-Spectrum Disorders (NMO-SD): State-of-the-Art and Future Perspectives
by: Giulia Ceglie, et al.
Published: (2020-07-01)

Epstein–Barr Virus and Human Endogenous Retrovirus in Japanese Patients with Autoimmune Demyelinating Disorders
by: Davide Cossu, et al.
Published: (2023-12-01)

Satralizumab as an add-on treatment in refractory pediatric AQP4-antibody-positive neuromyelitis optica spectrum disorder: a case report
by: Xiaojing Li, et al.
Published: (2023-10-01)

Emerging trends and research foci of neuromyelitis optica spectrum disorder: a 20-year bibliometric analysis
by: Yue Su, et al.
Published: (2023-06-01)

Treating seronegative neuromyelitis optica spectrum disorder with inebilizumab: a case report
by: Dominik Lehrieder, et al.
Published: (2023-11-01)

Relevance of bright spotty lesions in neuromyelitis optica spectrum disorders (NMOSD): a case series
by: Joe Joseph, et al.
Published: (2022-12-01)

Age of onset correlates with clinical characteristics and prognostic outcomes in neuromyelitis optica spectrum disorder
by: Yacen Hu, et al.
Published: (2022-12-01)

Overlapping anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis with neuromyelitis optica spectrum disorders: a case report
by: Jialin Pan, et al.
Published: (2022-05-01)

Granzyme B in circulating CD8+ T cells as a biomarker of immunotherapy effectiveness and disability in neuromyelitis optica spectrum disorders
by: Ziyan Shi, et al.
Published: (2022-11-01)

CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review
by: Virginia Rinaldi, et al.
Published: (2022-12-01)

Commentary: Targeting chemoattractant chemokine (C–C motif) ligand 2 derived from astrocytes is a promising therapeutic approach in the treatment of neuromyelitis optica spectrum disorders
by: Jingdan Zhang, et al.
Published: (2023-09-01)

Editorial: Epidemiology, diagnosis, prognosis and treatment of rare immune-mediated diseases of the central nervous system
by: Barbara M. P. Willekens, et al.
Published: (2023-12-01)

Neuromyelitis Optica Spectrum Disorder with Sick Sinus Syndrome: Two Cases and a Literature Review
by: Huiting Lin, et al.
Published: (2023-10-01)

Stem Cell Therapy in Neuroimmunological Diseases and Its Potential Neuroimmunological Complications
by: Franz Felix Konen, et al.
Published: (2022-07-01)

Editorial: Real-world study of multiple sclerosis and related diseases in developing countries
by: Jinming Han, et al.
Published: (2023-11-01)

Safety of SARS-CoV2 vaccination and COVID-19 short-term outcome in pediatric acquired demyelinating disorders of central nervous system: A single center experience
by: Gabriele Monte, et al.
Published: (2023-01-01)

Aquaporin-4 in Neuromyelitis Optica Spectrum Disorders: A Target of Autoimmunity in the Central Nervous System
by: Yoichiro Abe, et al.
Published: (2022-04-01)

Efficacy of Polyvalent Human Immunoglobulins in an Animal Model of Neuromyelitis Optica Evoked by Intrathecal Anti-Aquaporin 4 Antibodies
by: Benedikt Grünewald, et al.
Published: (2016-08-01)

Late-Onset Neuromyelitis Optica Spectrum Disorder Mimicking a Non-Arteritic Anterior Ischemic Optic Neuropathy–Case Report
by: Lech Sedlak, et al.
Published: (2023-06-01)

Regional spinal cord volumes and pain profiles in AQP4-IgG + NMOSD and MOGAD
by: Susanna Asseyer, et al.
Published: (2024-01-01)

Causal relationships between susceptibility and severity of COVID-19 and neuromyelitis optica spectrum disorder (NMOSD) in European population: a bidirectional Mendelian randomized study
by: Shengnan Wang, et al.
Published: (2023-12-01)

Double seropositive neuromyelitis optica associated with COVID-19: A case report
by: Dana Antonescu Ghelmez, et al.
Published: (2022-10-01)

A retrospective study of myelin oligodendrocyte glycoprotein antibody-associated disease from a clinical laboratory perspective
by: Yufei Wang, et al.
Published: (2023-09-01)

Serum Vitamin D Levels and Status in Thai Optic Neuritis Subjects: A Case-Control Study
by: Puangsricharoen B, et al.
Published: (2022-10-01)